199 related articles for article (PubMed ID: 9784014)
21. High plasma levels of 8-methoxypsoralen following bath water delivery in dermatological patients.
Kappes UP; Barta U; Merkel U; Balogh A; Elsner P
Skin Pharmacol Appl Skin Physiol; 2003; 16(5):305-12. PubMed ID: 12907835
[TBL] [Abstract][Full Text] [Related]
22. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides.
Child FJ; Mitchell TJ; Whittaker SJ; Scarisbrick JJ; Seed PT; Russell-Jones R
Clin Exp Dermatol; 2004 May; 29(3):231-6. PubMed ID: 15115499
[TBL] [Abstract][Full Text] [Related]
23. Assessment of 8-methoxypsoralen and ultraviolet a light effects on human stroma generation and function.
Legitimo A; Consolini R; Bencivelli W; Crimaldi G; Migliaccio P; Mosca F
Acta Haematol; 2006; 116(3):192-7. PubMed ID: 17016038
[TBL] [Abstract][Full Text] [Related]
24. Extracorporeal photochemotherapy.
Maeda A
J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
[TBL] [Abstract][Full Text] [Related]
25. Photopheresis (extracorporeal photochemotherapy).
Trautinger F; Just U; Knobler R
Photochem Photobiol Sci; 2013 Jan; 12(1):22-8. PubMed ID: 22859214
[TBL] [Abstract][Full Text] [Related]
26. [Documented effect of extra corporeal photopheresis on T-cell mediated diseases].
Kofoed K; Schiødt I; Gniadecki R
Ugeskr Laeger; 2011 Jun; 173(26):1869-74. PubMed ID: 21712008
[TBL] [Abstract][Full Text] [Related]
27. A method for the quantification of 8-methoxypsoralen by mass spectrometry for offline extracorporeal photopheresis.
Hähnel V; Dormann F; Nitsopoulos A; Friedle A; Ahrens N
Photochem Photobiol Sci; 2017 Feb; 16(2):193-200. PubMed ID: 27976780
[TBL] [Abstract][Full Text] [Related]
28. [Update on extracorporeal photopheresis].
Just U; Knobler R
Hautarzt; 2015 Nov; 66(11):804-9. PubMed ID: 26431837
[TBL] [Abstract][Full Text] [Related]
29. Matrix-dependent absorption of 8-methoxypsoralen in extracorporeal photopheresis.
Hähnel V; Weber I; Tuemmler S; Graf B; Gruber M; Burkhardt R; Ahrens N
Photochem Photobiol Sci; 2020 Aug; 19(8):1099-1103. PubMed ID: 32638713
[TBL] [Abstract][Full Text] [Related]
30. [Influence of retinoids on the bioavailability of methoxy-8-psoralen].
Beani JC; Bonnot D; Berthod F; Boitard M; Reymond JL; Beriel H; Amblard P
Ann Dermatol Venereol; 1991; 118(4):273-5. PubMed ID: 2069337
[TBL] [Abstract][Full Text] [Related]
31. Small-scale extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma: a report of 3 cases.
Schreiner T; Gaczkowski A; Scharffetter-Kochanek K; Borberg H
Transfus Apher Sci; 2005 Apr; 32(2):197-203. PubMed ID: 15784454
[TBL] [Abstract][Full Text] [Related]
32. [The pharmacokinetic and toxicologic profile of 8-methoxypsoralen. The basis for safe and effective PUVA therapy].
Schmid J; Brickl R; Koss FW
Derm Beruf Umwelt; 1988; 36(6):177-85. PubMed ID: 3069432
[TBL] [Abstract][Full Text] [Related]
33. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
Weber F; Schmuth M; Sepp N; Fritsch P
Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
[TBL] [Abstract][Full Text] [Related]
34. Influence of metoclopramide on the pharmacokinetics of 8-methoxypsoralen.
Studer-Sachsenberg EM; Piletta PA; Fathi M; Saurat JH; Salomon D
Dermatology; 1997; 195(1):81-3. PubMed ID: 9267751
[TBL] [Abstract][Full Text] [Related]
35. Extracorporeal photochemotherapy (ECP) in children.
Perseghin P
Transfus Apher Sci; 2013 Apr; 48(2):161-2. PubMed ID: 23809815
[No Abstract] [Full Text] [Related]
36. Management of cutaneous T-Cell lymphoma patients with extracorporeal photopheresis. The Hellenic experience.
Siakantaris MP; Tsirigotis P; Stavroyianni N; Argyropoulos KV; Girkas K; Pappa V; Chondropoulos S; Papadavid E; Sakellari I; Anagnostopoulos A; Antoniou C; Dervenoulas J
Transfus Apher Sci; 2012 Apr; 46(2):189-93. PubMed ID: 22178592
[TBL] [Abstract][Full Text] [Related]
37. Photopheresis in the treatment of cutaneous T-cell lymphoma: current status.
Zic JA
Curr Opin Oncol; 2012 Jan; 24 Suppl 1():S1-10. PubMed ID: 22157241
[TBL] [Abstract][Full Text] [Related]
38. Combination therapy with extracorporeal photopheresis, interferon-alpha, PUVA and topical corticosteroids in the management of Sézary syndrome.
Booken N; Weiss C; Utikal J; Felcht M; Goerdt S; Klemke CD
J Dtsch Dermatol Ges; 2010 Jun; 8(6):428-38. PubMed ID: 20180887
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of cell death after treatment with extracorporeal photopheresis.
Daniele N; Del Proposto G; Cerrone P; Sinopoli S; Sansone L; Gadaleta DI; Lanti A; Ferraro AS; Spurio S; Scerpa MC; Zinno F; Adorno G; Isacchi G
Transfus Apher Sci; 2012 Feb; 46(1):53-7. PubMed ID: 22138605
[TBL] [Abstract][Full Text] [Related]
40. [Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases].
Owsianowski M; Garbe C; Ramaker J; Orfanos CE; Gollnick H
Hautarzt; 1996 Feb; 47(2):114-23. PubMed ID: 8868455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
